MY142361A - Sustained-release pharmaceutical composition for pulmonary administration - Google Patents

Sustained-release pharmaceutical composition for pulmonary administration

Info

Publication number
MY142361A
MY142361A MYPI20040633A MYPI20040633A MY142361A MY 142361 A MY142361 A MY 142361A MY PI20040633 A MYPI20040633 A MY PI20040633A MY PI20040633 A MYPI20040633 A MY PI20040633A MY 142361 A MY142361 A MY 142361A
Authority
MY
Malaysia
Prior art keywords
pharmaceutical composition
sustained
release pharmaceutical
pulmonary administration
active substance
Prior art date
Application number
MYPI20040633A
Other languages
English (en)
Inventor
Akira Yamamoto
Keigo Yamada
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of MY142361A publication Critical patent/MY142361A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/731—Carrageenans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MYPI20040633A 2003-02-26 2004-02-26 Sustained-release pharmaceutical composition for pulmonary administration MY142361A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003049019 2003-02-26

Publications (1)

Publication Number Publication Date
MY142361A true MY142361A (en) 2010-11-30

Family

ID=32923305

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20040633A MY142361A (en) 2003-02-26 2004-02-26 Sustained-release pharmaceutical composition for pulmonary administration

Country Status (9)

Country Link
US (1) US20060078504A1 (https=)
EP (1) EP1600170A4 (https=)
JP (1) JPWO2004075920A1 (https=)
KR (1) KR20050105490A (https=)
CN (1) CN1744917B (https=)
CA (1) CA2512434C (https=)
MY (1) MY142361A (https=)
TW (1) TW200500085A (https=)
WO (1) WO2004075920A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130150810A1 (en) * 2002-04-30 2013-06-13 The Population Council, Inc. Intravaginal ring for the delivery of unique combinations of antimicrobial compositions
US20080131454A1 (en) * 2006-12-05 2008-06-05 Marinomed Biotechnologie Gmbh Methods and Compositions for the Treatment of Rhinovirus Infections with Carrageenan
PL2178533T3 (pl) * 2007-08-24 2013-08-30 Marinomed Biotechnologie Gmbh Kompozycja przeciwwirusowa zawierająca siarczanowany polisacharyd: jota-karagen
CA2726221C (en) * 2008-07-01 2017-03-28 Marinomed Biotechnologie Gmbh Antiallergic marine biopolymers
EP2233130A1 (en) * 2009-03-23 2010-09-29 Genepharm (Europe) Trading Limited A sustained release oral composition of an antipsychotic agent
CN114191418B (zh) * 2021-12-21 2023-06-09 丽珠医药集团股份有限公司 噻托溴铵双层微球及其制备方法和噻托溴铵缓释吸入剂

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192528A (en) * 1985-05-22 1993-03-09 Liposome Technology, Inc. Corticosteroid inhalation treatment method
US5200195A (en) * 1991-12-06 1993-04-06 Alza Corporation Process for improving dosage form delivery kinetics
CA2115444C (en) * 1992-06-12 2000-10-03 Yuji Makino Preparation for intratracheobronchial administration
US5612053A (en) * 1995-04-07 1997-03-18 Edward Mendell Co., Inc. Controlled release insufflation carrier for medicaments
US6126919A (en) * 1997-02-07 2000-10-03 3M Innovative Properties Company Biocompatible compounds for pharmaceutical drug delivery systems
JP2000070327A (ja) * 1998-09-01 2000-03-07 Kao Corp 鼻腔内洗浄具
US6579968B1 (en) * 1999-06-29 2003-06-17 Palatin Technologies, Inc. Compositions and methods for treatment of sexual dysfunction
US6461639B2 (en) * 2000-05-01 2002-10-08 Aeropharm Technology, Inc. Core formulation
NL1015288C2 (nl) * 2000-05-24 2001-12-14 Peter Ferdinand Elbers Preparaat voor het stabiliseren van de beschermlaag op het epitheel van het hoornvlies of de longblaasjes.
US6989156B2 (en) * 2001-04-23 2006-01-24 Nucryst Pharmaceuticals Corp. Therapeutic treatments using the direct application of antimicrobial metal compositions
US6475468B2 (en) * 2001-02-15 2002-11-05 Aeropharm Technology Incorporated Modulated release particles for aerosol delivery
US6749845B2 (en) * 2001-02-15 2004-06-15 Aeropharm Technology, Inc. Modulated release particles for lung delivery
US6551578B2 (en) * 2001-02-15 2003-04-22 Aeropharm Technology Incorporated Modulated release particles for aerosol delivery
JP2002255852A (ja) * 2001-03-01 2002-09-11 Toa Eiyo Ltd 口内炎用スプレー製剤
JP2003040766A (ja) * 2001-07-26 2003-02-13 Kao Corp 鼻腔内洗浄具

Also Published As

Publication number Publication date
EP1600170A4 (en) 2010-12-29
CN1744917B (zh) 2010-05-05
TW200500085A (en) 2005-01-01
TWI332403B (https=) 2010-11-01
HK1083768A1 (zh) 2006-07-14
JPWO2004075920A1 (ja) 2006-06-01
CA2512434C (en) 2012-01-03
EP1600170A1 (en) 2005-11-30
KR20050105490A (ko) 2005-11-04
US20060078504A1 (en) 2006-04-13
CN1744917A (zh) 2006-03-08
CA2512434A1 (en) 2004-09-10
WO2004075920A1 (ja) 2004-09-10

Similar Documents

Publication Publication Date Title
EE05287B1 (et) Tsklopentanoindoolid, nende kasutamine ravimi valmistamiseks ning neid sisaldav farmatseutiline kompositsioon
TW200510375A (en) New compounds
UA96449C2 (en) Stable laquinimod preparations
MY161079A (en) Tamper resistant oral pharmaceutical dosage forms comprising an opioid analgesic
TNSN08284A1 (en) Masking the taste of powders
NO20071044L (no) Doseformer med enteraltbelagte tablettkjerner
GR1003658B (el) Δισκιο μητρας που καθιστα δυνατη την παρατεταμενη απελευθερωση της τριμεταζιδινης μετα χορηγηση δια της στοματικης οδου
DE60336225D1 (de) Neue pharmazeutische zusammenstezungen, flibanserin polymorph a enthaltend
TNSN07337A1 (en) Pharmaceutical composition comprising an indolylmaleimide derivative
ATE252377T1 (de) Kontrolliert freisetzende pharmazeutische zusammensetzung mit tilidinmesylat als wirkstoff
NO20023551L (no) Ibuprofen-inneholdende aktivt middel-preparat
ZA200208761B (en) Pharmaceutical form of administration for peptides, methods for its production and use.
SG152257A1 (en) Topical preparation containing ambroxol
DE60124144D1 (de) Pharmazeutische zusammenstellungen zur verstärkung der artzneimitteleffekte
SE0102440D0 (sv) New compound
GR20010100377A (el) Φαρμακευτικη συνθεση περιεχουσα σιταλοπραμη
MY142361A (en) Sustained-release pharmaceutical composition for pulmonary administration
DE602004016963D1 (en) Therapeutisches system mit amoxicillin und clavulansäure
TW200800977A (en) A new salt
DE60007074D1 (de) Sulfatierte phosphatidylinositole, ihre herstellung und verwendung
ATE460934T1 (de) Pharmazeutische zubereitungen von ciprofloxacin
WO2005049024A3 (de) Feste pharmazeutische zubereitungsform
UA97355C2 (ru) Фармацевтическая композиция, включающая монтелукаст
GB9917290D0 (en) Pharmaceutical composition
UA88284C2 (ru) Твердая лекарственная форма, которая содержит действующее вещество из группы ингибиторов обратного захвата моноаминовых нейротрансмиттеров с 2,3-двухзамещенным тропановым скелетом, способ ее получения и применения